IPMD, Inc.
IPMD, Inc. is a San Mateo-based emotional AI company that builds the EchoAI (Project M) multimodal CNN platform to detect facial micro-expressions and emotions for telemedicine, enterprise hiring, and consumer self-awareness applications.
- Company typePrivate
- Founded2016
- HeadquartersSan Mateo, United States
- Headcount11–50
- GTM typeB2B and B2C
- OfferingSoftware
What IPMD, Inc. does
IPMD, Inc. is a privately held emotional AI company founded in 2016 and headquartered in San Mateo, California. The company has developed Project M (also marketed as EchoAI), a custom CNN-based platform that performs multimodal analysis of facial expressions, micro-expressions, tone of voice, and language to detect eight primary emotions across multiple intensity levels, claiming 95%+ ROC/AUC accuracy and a 96% emotional comprehension rate. The platform was trained over seven years on more than 500,000 labeled data points produced by nearly 500 collaborators contributing 130,000+ hours of emotional mapping.
The company distributes its technology through three commercial vectors: a freemium EchoAI Mobile App for individual consumers; the IEAI Interview Platform, an enterprise B2B SaaS product applying emotion AI to candidate assessment; and an FDA Class 1 SaMD-registered, HIPAA-compliant Telemedicine Platform that functions as a Clinical Decision Support System for remote patient emotional assessment (commercialized via partnerships such as BeWell Health). A social-impact sub-brand, EchoBloom Initiatives, runs donation-funded AI-assisted art therapy programs for neurodiverse individuals.
Revenue is sourced from mobile app subscriptions, enterprise licensing, telemedicine platform integration deals, and small-scale donations. The company has raised a disclosed $150,000 pre-seed round led by Jumpstart Foundry (2023), received an earlier Google grant (2019), and operates from a small founding team augmented by a university internship pipeline across nine partner institutions.
IPMD, Inc. firmographics
Firmographics- Name
- IPMD, Inc.
- Legal name
- IPMD, Inc.
- Website
- https://ipmdinc.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- IPMD, Inc. is a San Mateo-based emotional AI company that builds the EchoAI (Project M) multimodal CNN platform to detect facial micro-expressions and emotions for telemedicine, enterprise hiring, and consumer self-awareness applications.
- Ownership category
- akta.pro rank
IPMD, Inc. industry classification
Industry- Product category
- Emotional AI Software
- NAICS
- Telephone Call Centers (56142), Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Emotion, Sentiment & Paralinguistic Intelligence (HDAAAFAI)
- akta.pro secondary industries
- Conversational AI Platforms (chat/voice bots, orchestration) (HDAAAFAC), Contact Center Speech AI (agent assist, IVR automation) (HDAAAFAL), Workplace Mental Health & EAP-Integrated Teletherapy Platforms (HLALAEAK)
Keywords
Where IPMD, Inc. is headquartered
LocationHeadquarters
- HQ city
- San Mateo
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
IPMD, Inc. business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- EchoAI Mobile App Subscriptions: Freemium model with free tier offering basic emotional status and mood status tracking. Premium tier provides comprehensive features including emotion frequency, emotion status frequency, emotion pairs, mood frequency, mood status frequency, and mood pairs analysis. Mobile app available for download.
- IEAI Interview Platform (Enterprise Licensing): B2B SaaS platform for enterprise talent acquisition. Provides data-driven candidate assessment, emotion-based questioning, and comprehensive analytics for hiring decisions. Revenue from enterprise seat licenses or platform subscriptions.
- Telemedicine Platform Licensing: Integration of Emotional AI into healthcare systems as Medical Agentic AI. Revenue from partnerships with healthcare providers and telemedicine platforms. HIPAA-compliant, FDA Class 1 medical device registration (SaMD).
- EchoBloom Donations: Donation-based funding for EchoBloom Initiatives supporting neurodiverse artists and AI art therapy programs. Donation tiers starting at $5 with Digital Gallery access rewards. 40% to artists, 20% to AI R&D, 40% to operations.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Monthly | Free Tier - Basic emotional analysis |
| Subscription | Monthly | Premium Tier - Comprehensive emotional insights |
| Subscription | Monthly | EchoBloom Donation Tiers |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels7 records
IPMD, Inc. product offering
Product offeringCore offering
IPMD develops and sells EchoAI, an emotional intelligence platform that uses proprietary CNN-based AI to detect micro-expressions and analyze eight primary emotions in real time across facial, vocal, and linguistic inputs. Its commercial offerings include a consumer-facing EchoAI Mobile App (freemium subscription), an IEAI Interview Platform for enterprise hiring, a Class 1 FDA-registered Telemedicine Platform that integrates emotional AI into virtual care workflows, and the EchoBloom Initiatives art therapy program.
Product overview
IPMD offers a platform-plus-modules architecture centered on EchoAI, its flagship emotional intelligence platform. The core Project M technology powers all offerings through advanced CNN-based facial micro-expression analysis achieving 95%+ accuracy. The EchoAI Mobile App extends these capabilities to consumers via mobile devices. Specialized modules include the IEAI Interview Platform for AI-powered talent acquisition and the Emotional AI Telemedicine Platform (Class 1 CDSS) for remote patient emotional assessment. EchoBloom Initiatives represents a social impact sub-brand focused on inclusive AI-supported art therapy for neurodiverse and trauma-affected individuals. The ecosystem is unified by shared emotional AI technology that analyzes facial expressions, voice, and language in real-time across all products.
Differentiator
Problem solved
Functional benefit
Products and services
- Project M (Emotional AI Platform) Core emotional AI platform using advanced CNN-based algorithms to detect micro-expressions and analyze 8 primary emotions across multiple intensity levels, achieving over 95% ROC/AUC accuracy on 500,000+ labeled data points covering 400,000+ emotional variables.
- EchoAI Platform Flagship emotional intelligence platform evaluating users' emotional states through multimodal analysis of facial expressions, tone of voice, language, and micro-expressions, offering a 96% emotional comprehension rate with personalized empathy-driven responses as a digital mirror.
- EchoAI Mobile App Consumer-facing mobile application delivering EchoAI capabilities directly to individuals; users capture selfie videos through their mobile camera to receive real-time insights into their emotional state, enabling self-awareness and emotional intelligence development under a freemium model.
- IEAI Interview Platform AI-powered hiring platform that uses facial emotional AI technology to assess candidate suitability beyond resumes and interviews; analyzes micro-expressions including joy, contempt, anger, and fear, with emotion-based adaptive questioning, candidate profile management, and data-driven hiring analytics for enterprise talent acquisition teams.
- Emotional AI Telemedicine Platform Class 1 CDSS (Clinical Decision Support System) and FDA-registered SaMD Class 1 medical device that integrates EchoAI into telemedicine workflows to help physicians understand patient emotional states during virtual consultations; provides real-time emotional analysis during video calls and exports comprehensive 24-hour post-session emotional analysis PDF reports, HIPAA-compliant.
- EchoBloom Initiatives Creative and inclusive sub-brand program that combines individuals with disabilities, human artists, and Emotional AI to co-create transformative art for healing and dignity; supports AI-supported art therapy for participants with autism, intellectual and developmental disabilities, dementia, and trauma, funded through a donation-based model with Digital Gallery access rewards.
Quantifiable outcome
- 96% emotional comprehension rate achieved through 130,000+ hours of training
- +2 more outcomes
Companies that use IPMD, Inc.
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles4 records
IPMD, Inc. technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability8 records
Feature6 records
IPMD, Inc. partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core and minor.
- Google (GCP, Cloud Build Partner)coreReceived Google funding to build a secure, scalable RESTful emotional AI API. Named a Google Cloud Build Partner ensuring scalable emotional AI development. Accepted into Google's GCP Surge Program empowering infrastructure with elite cloud tools.
- NVIDIA (Inception Program, Capital Connect)coreSelected for NVIDIA's Inception Program gaining access to advanced AI mentorship and GPU acceleration. Invited to NVIDIA Capital Connect opening direct access to leading AI investors. Won Texas Children's Hospital Hackathon with emotional AI solution.
- AWS ActivatecoreAWS Active Member supporting cloud-based scaling of EchoAI platform through AWS Activate program for startups.
- IBM Startup ProgramcoreIBM Startup Program member supporting development and technology infrastructure.
- Startup World CupcoreSelected among top 15 startups to compete at Silicon Valley Regional Finals on August 3, 2023 at the Computer History Museum.
- Hello TomorrowcoreNamed Deep Tech Pioneers by Hello Tomorrow, a mission-driven global organization accelerating deep technologies to solve pressing societal changes.
- BeWell HealthcorePartnership to integrate EchoAI into next-generation Medical Agentic AI for telehealth systems to assess emotional states alongside medical data.
- House of GracecoreIPMD signed MOU with House of Grace for EchoBloom Initiatives supporting neurodiverse individuals through AI art therapy.
- Texas Children's HospitalcoreWon Touchless Experience Category of Texas Children's Hospital Healthcare Hackathon with Project M emotional AI solution for hospital environments.
- University Partnerships (Waterloo, SJSU, ESADE, Columbia, NYU, Vanderbilt, UPenn, Juilliard, UC Berkeley)minorIPMD Internship Programs are qualified for university course credits including IB 99/199, MCB 99/199, STAT 199, Econ 197, PP199, Cog Sci 197, PH 297, DS 97/197, and CS 97/197.
Scale indicators9 records
Recent moves6 records
Expansion highlights6 records
IPMD, Inc. competitors and assessment
Company assessmentDirect peers
- Cogito: Real-time emotional AI for call-center agent coaching, similar in combining voice + behavior analytics. Comparable to IPMD's emotional AI for enterprise customer interaction use cases.
- Kairos: Face recognition and emotion detection API provider. Comparable to IPMD's CNN-based facial emotion analysis sold as developer/enterprise APIs.
- Realeyes: Emotion-AI platform measuring attention and emotion via webcam for advertising effectiveness and market research. Directly comparable to IPMD's facial emotion-recognition technology and consumer/enterprise data output.
- Hume AI: Voice- and expression-based emotional AI foundation models with a developer API. Comparable to EchoAI's multimodal (face + voice + language) emotion analysis and similar positioning as an emotion-AI platform for builders.
- Sensely: Virtual medical assistant with empathy/emotional intelligence for telemedicine triage. Comparable to IPMD's Emotional AI Telemedicine Platform as a clinical decision support product integrated into telehealth workflows.
- Affectiva (Smart Eye): Pioneer in facial emotion AI / affective computing, now part of Smart Eye. Closest direct competitor to IPMD's Project M / EchoAI in terms of multimodal emotion detection from video and similar enterprise/automotive customer base.
Others
- Pactum AI: Conversational AI for enterprise procurement negotiations. Adjacent rather than direct, but illustrative of how AI-driven conversational/intelligence platforms are being productized for specific enterprise verticals in a similar go-to-market motion to IPMD's IEAI.
Emerging players
- Empath: Voice emotion AI (Japan-based) used for mental wellness and call-center monitoring. Adjacent technology overlap with IPMD's voice tone analysis component.
- Wysa: AI mental-health companion using conversational AI for emotional support. Adjacent to IPMD's telemedicine emotional-AI use case but focused on direct-to-consumer mental health rather than physician CDSS.
Broad incumbents
- Microsoft Azure Cognitive Services (Face API): Hyperscaler emotion/face API that IPMD explicitly benchmarks against. Broader incumbent offering overlapping emotion-detection capability inside a much larger AI/cloud portfolio.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights6 records
Customer concentration
IPMD, Inc. social profiles
Digital presenceIPMD, Inc. compliance and trust
Trust signalCompliance2 records
IPMD, Inc. financial estimates
Financial estimateRevenue estimate
Valuation estimate
IPMD, Inc. leadership team
Management profileNumber of profiles
Profiles9 records
IPMD, Inc. funding detail
Funding detailFunding overview
Funding rounds1 record
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
IPMD, Inc. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about IPMD, Inc.
What does IPMD, Inc. do?
IPMD develops and sells EchoAI, an emotional intelligence platform that uses proprietary CNN-based AI to detect micro-expressions and analyze eight primary emotions in real time across facial, vocal, and linguistic inputs. Its commercial offerings include a consumer-facing EchoAI Mobile App (freemium subscription), an IEAI Interview Platform for enterprise hiring, a Class 1 FDA-registered Telemedicine Platform that integrates emotional AI into virtual care workflows, and the EchoBloom Initiatives art therapy program.
Is IPMD, Inc. a public or private company?
IPMD, Inc. is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was IPMD, Inc. founded?
IPMD, Inc. was founded in 2016. It employs 11 to 50 people.
Where is IPMD, Inc. based?
IPMD, Inc. is headquartered in San Mateo, United States, in the North America region.
How does IPMD, Inc. make money?
Four revenue lines are on record. EchoAI Mobile App Subscriptions are the primary driver. The others are IEAI Interview Platform (Enterprise Licensing), telemedicine Platform Licensing and echoBloom Donations.
Who are IPMD, Inc.'s main competitors?
Direct peers on record are Cogito, Kairos, Realeyes, Hume AI, Sensely and Affectiva (Smart Eye). Pactum AI is listed as an others. Emerging players are Empath and Wysa. Microsoft Azure Cognitive Services (Face API) is listed as a broad incumbent.
Does IPMD, Inc. have an API?
Yes. IPMD received Google funding to build a secure, scalable RESTful emotional AI API. The API enables real-time video feed analysis for emotional state detection. EchoAI platform provides an Emotional AI virtual API calling capability for telemedicine applications.
What industry is IPMD, Inc. in?
IPMD, Inc.'s product category is Emotional AI Software. Its primary akta.pro industry code is HDAAAFAI, Emotion, Sentiment & Paralinguistic Intelligence, with a secondary code of HDAAAFAC, Conversational AI Platforms (chat/voice bots, orchestration). Its NAICS code is 56142 and its SIC code is 7372.